Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Sep 08, 2024
Episode
240
Soundcloud
Share
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Stephen Liu discusses daily highlights from the conference. Dr. Caicun Zhou discusses the results of ivonescimab versus pembrolizumab in the first-line HARMONi-2 study. Dr. Tina Cascone discusses preliminary outcomes from the perioperative NeoCOAST-2 study, and Dr. Marina Chiara Garassino outlines the potential QCS-NMR TROP2 biomarker using data from TROPION-Lung01. Dr. Matthew Smeltzer shares the results of the 2024 IASLC Global Survey on Biomarker Testing and how they compare to findings from the previous survey in 2018.
Guest
Tina Cascone
MD
Associate Professor, Department of Thoracic/Head and Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Marina Chiara Garassino
MD
Director, Thoracic Oncology Program and Professor of Medicine
University of Chicago
Matthew Smeltzer
PhD, MStat
Associate Professor, Division of Epidemiology, Biostatistics, and Environmental Health
University of Memphis
Caicun Zhou
MD, PhD
Director of the Department of Oncology
Shanghai Pulmonary Hospital
Cancer Institute of Tongji University Medical School
Tongji University
